Article
Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis
18 Feb 2020
Abstract excerpt
OBJECTIVE: Epstein-Barr virus (EBV) is a well-recognized oncogenic virus that can induce host cell metabolic reprogramming and tumorigenesis by targeting vital metabolic enzymes or regulators. This study aims to explore the role of wild-type isocitrate dehydrogenase 2 (IDH2) in metabolic reprogramming and tumorigenesis induced by EBV-encoded latent membrane protein 1 (LMP1). METHODS: Mechanistic dissection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
